Sugarman brachydactyly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:498602OMIM:272150Q71.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Sugarman brachydactyly is a very rare inherited condition that mainly affects the development of the fingers and toes. The name comes from the Greek word 'brachy' meaning short, and 'dactyly' meaning fingers or toes. People with this condition are born with unusually short fingers and toes because some of the small bones inside them (called phalanges) are either very small or fused together. This is sometimes also called brachydactyly type E2 or Sugarman syndrome in older medical literature, though naming can vary between sources. The condition is present from birth and is caused by changes (mutations) in a specific gene that guides how bones form during fetal development. Beyond the hands and feet, some individuals may also have short stature and subtle facial features, though the short digits are the most noticeable sign. The condition does not typically affect intelligence or lifespan. Because Sugarman brachydactyly is so rare, treatment is focused on managing symptoms rather than curing the underlying cause. Orthopedic care, occupational therapy, and physical therapy can help people adapt and maintain good hand function. Surgery is occasionally considered in specific cases to improve function or appearance. Most people with this condition live full, independent lives with appropriate support.

Also known as:

Key symptoms:

Unusually short fingersUnusually short toesFused or missing small bones in the fingers or toesShort overall statureBroad or stubby fingertipsLimited range of motion in the fingersSubtle differences in facial appearance in some individuals

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Sugarman brachydactyly.

View clinical trials →

No actively recruiting trials found for Sugarman brachydactyly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Sugarman brachydactyly community →

No specialists are currently listed for Sugarman brachydactyly.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Sugarman brachydactyly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Sugarman brachydactylyForum →

No community posts yet. Be the first to share your experience with Sugarman brachydactyly.

Start the conversation →

Latest news about Sugarman brachydactyly

No recent news articles for Sugarman brachydactyly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific bones in my child's hands and feet are affected, and how will this change as they grow?,Should we see a hand surgeon, and if so, when would surgery be most beneficial?,What type of occupational therapy would help most, and how often should we go?,Since this condition is genetic, what is the chance that other family members or future children could be affected?,Are there any clinical trials or research studies we could participate in?,What signs should prompt us to come back sooner between scheduled appointments?,Are there any patient communities or support groups for families dealing with brachydactyly conditions?

Common questions about Sugarman brachydactyly

What is Sugarman brachydactyly?

Sugarman brachydactyly is a very rare inherited condition that mainly affects the development of the fingers and toes. The name comes from the Greek word 'brachy' meaning short, and 'dactyly' meaning fingers or toes. People with this condition are born with unusually short fingers and toes because some of the small bones inside them (called phalanges) are either very small or fused together. This is sometimes also called brachydactyly type E2 or Sugarman syndrome in older medical literature, though naming can vary between sources. The condition is present from birth and is caused by changes (

How is Sugarman brachydactyly inherited?

Sugarman brachydactyly follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Sugarman brachydactyly typically begin?

Typical onset of Sugarman brachydactyly is neonatal. Age of onset can vary across affected individuals.